Authors: Maattanen, L Auvinen, A Stenman, UH Tammela, T Rannikko, S Aro, J Juusela, H Hakama, M

Citation: L. Maattanen et al., Three-year results of the Finnish prostate cancer screening trial, J NAT CANC, 93(7), 2001, pp. 552-553

Authors: Hakama, M Aro, J Auvinen, A Juusela, H Maattanen, L Stenman, UH Tammela, TLJ

Citation: M. Hakama et al., Randomized screening trial for prostate cancer in Finland, EUR UROL, 39, 2001, pp. 32-32

Authors: Makinen, T Tammela, TLJ Hakama, M Stenman, UH Rannikko, S Aro, J Juusela, H Maattanen, L Auvinen, A

Citation: T. Makinen et al., Prostate cancer screening within a prostate specific antigen range of 3 to3.9 ng./ml.: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests, J UROL, 166(4), 2001, pp. 1339-1342

Authors: Finne, P Finne, R Auvinen, A Juusela, H Aro, J Maattanen, L Hakama, M Rannikko, S Tammela, TLJ Stenman, UH

Citation: P. Finne et al., Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network, UROLOGY, 56(3), 2000, pp. 418-422

Authors: Pyrhonen, S Salminen, E Ruutu, M Lehtonen, T Nurmi, M Tammela, T Juusela, H Rintala, E Hietanen, P Kellokumpu-Lehtinen, PL

Citation: S. Pyrhonen et al., Prospective randomized trial of interferon alfa-2a plus vinblastine versusvinblastine alone in patients with advanced renal cell cancer, J CL ONCOL, 17(9), 1999, pp. 2859-2867

Authors: Maattanen, L Auvinen, A Stenman, UH Rannikko, S Tammela, T Aro, J Juusela, H Hakama, M

Citation: L. Maattanen et al., European randomized study of prostate cancer screening: first-year resultsof the Finnish trial, BR J CANC, 79(7-8), 1999, pp. 1210-1214